Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Do common CNNM2 genetic variants lower serum magnesium levels?

Common noncoding variants in CNNM2 are associated with slightly lower circulating serum magnesium concentrations.

PlausibleJune 19, 20266 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Common genetic variants in CNNM2 are associated with lower serum magnesium levels in genome-wide association studies.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Genome-wide association studies consistently link common intronic CNNM2 variants (e.g., rs11191580) to modest reductions in serum magnesium. Mechanistically, these variants appear to reduce CNNM2 expression or activity in distal convoluted tubule cells, impairing basolateral Mg2+ efflux and slightly decreasing renal reabsorption efficiency, which lowers circulating magnesium.

Verified conclusion

An assessment of the association between genetic variations in the CNNM2 gene and circulating serum magnesium levels reveals a well-documented genetic-physiological relationship.

Genetic and epidemiological evidence

  • Robust statistical associations: Genome-wide association studies (GWAS) involving large cohorts have consistently identified the chromosome 10q24 locus, specifically containing the CNNM2 gene, as a major locus for magnesium homeostasis. The common intronic single-nucleotide polymorphism (SNP) rs11191580 serves as the primary genetic index marker.
  • Modest systemic impact: Unlike rare coding mutations in CNNM2 that lead to severe, familial renal magnesium wasting (hypomagnesemia), these common variants exert a subtle influence. Each risk allele at rs11191580 reduces serum magnesium concentrations by approximately 0.01 to 0.03 standard deviations, reflecting a regulatory rather than structural defect.

Mechanistic explanations

  • Renal localization and function: CNNM2 (cyclin M2) is highly expressed in the basolateral membrane of the distal convoluted tubule (DCT) within the kidney, which is the primary site for fine-tuning renal magnesium reabsorption.
  • Basolateral efflux pathway: Renal transcellular reabsorption requires magnesium to enter apical channels (TRPM6) and exit the basolateral membrane into the bloodstream. CNNM2 is essential for this basolateral efflux step, either directly facilitating sodium-coupled magnesium extrusion or regulating adjacent transport partners.
  • Systemic consequence: Common variants alter the expression or activity of CNNM2, decreasing the efficiency of basolateral efflux and active renal reabsorption, which results in slightly increased urinary excretion and lower circulating serum levels.

Clinical implications for a 51-year-old female

  • Potential for subclinical deficiency: While these common variants do not typically cause symptomatic hypomagnesemia in isolation, they represent a chronic genetic vulnerability.
  • Compounding risk factors: In a 51-year-old female, this genetic predisposition may interact with environmental factors such as dietary intake, age-related changes in gastrointestinal absorption, or medications (e.g., proton pump inhibitors or diuretics) to increase the likelihood of subclinical magnesium deficiency.

Bottom line

Common genetic variants in CNNM2 (such as rs11191580) are robustly associated with slightly lower serum magnesium levels. This association is driven by subtle alterations in basolateral magnesium extrusion within the renal distal convoluted tubule, reducing overall reabsorption efficiency and lowering circulating magnesium.

References

  1. Genome-Wide Association Studies of Serum Magnesium, Potassium, and Sodium Concentrations Identify Six Loci Influencing Serum Magnesium Levels — pmc.ncbi.nlm.nih.gov ↗
  2. Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study — pmc.ncbi.nlm.nih.gov ↗
  3. Membrane Topology and Intracellular Processing of Cyclin M2 (CNNM2)* — pmc.ncbi.nlm.nih.gov ↗
  4. Novel Aspects of Renal Magnesium Homeostasis — pmc.ncbi.nlm.nih.gov ↗
  5. CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia. — pmc.ncbi.nlm.nih.gov ↗
  6. Novel Aspects of Renal Magnesium Homeostasis — frontiersin.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→